ACXP vs. QTUM
ACXP (Acurx Pharmaceuticals, Inc.) is a stock, while QTUM (Defiance Quantum ETF) is Technology Equities fund tracking the BlueStar Machine Learning and Quantum Computing Index. Over the past 5 years, ACXP returned -57.93%/yr vs 25.84%/yr for QTUM. At a 0.17 correlation, their price movements are largely independent.
Performance
ACXP vs. QTUM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ACXP achieves a -36.14% return, which is significantly lower than QTUM's 30.78% return.
ACXP
- 1D
- -9.14%
- 1M
- 3.25%
- 6M
- -40.89%
- YTD
- -36.14%
- 1Y
- -81.54%
- 3Y*
- -66.55%
- 5Y*
- -57.93%
- 10Y*
- —
QTUM
- 1D
- -3.40%
- 1M
- -11.80%
- 6M
- 21.36%
- YTD
- 30.78%
- 1Y
- 54.31%
- 3Y*
- 40.96%
- 5Y*
- 25.84%
- 10Y*
- —
ACXP vs. QTUM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ACXP Acurx Pharmaceuticals, Inc. | -36.14% | -84.71% | -78.75% | -3.77% | -7.90% | -27.37% |
QTUM Defiance Quantum ETF | 30.78% | 36.65% | 50.54% | 39.86% | -28.80% | 13.88% |
Correlation
The correlation between ACXP and QTUM is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jun 25, 2021 | 0.17 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ACXP vs. QTUM — Risk / Return Rank
ACXP
QTUM
ACXP vs. QTUM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Acurx Pharmaceuticals, Inc. (ACXP) and Defiance Quantum ETF (QTUM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ACXP | QTUM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.22 | ||
| Sortino ratioReturn per unit of downside risk | -2.80 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 1.30 | -0.35 |
| Calmar ratioReturn relative to maximum drawdown | -0.95 | 3.58 | -4.53 |
| Martin ratioReturn relative to average drawdown | -1.25 | 11.44 | -12.69 |
Loading charts...
Drawdowns
ACXP vs. QTUM - Drawdown Comparison
The maximum ACXP drawdown since its inception was -99.14%, which is greater than QTUM's maximum drawdown of -38.45%. Use the drawdown chart below to compare losses from any high point for ACXP and QTUM.
Loading charts...
Drawdown Indicators
| ACXP | QTUM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.14% | -38.45% | -60.69% |
Max Drawdown (1Y)Largest decline over 1 year | -85.94% | -15.26% | -70.68% |
Max Drawdown (3Y)Largest decline over 3 years | -98.83% | -25.39% | -73.44% |
Max Drawdown (5Y)Largest decline over 5 years | -98.88% | -38.45% | -60.43% |
Current DrawdownCurrent decline from peak | -98.99% | -15.19% | -83.80% |
Average DrawdownAverage peak-to-trough decline | -69.91% | -8.22% | -61.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 65.07% | 4.76% | +60.31% |
Volatility
ACXP vs. QTUM - Volatility Comparison
Acurx Pharmaceuticals, Inc. (ACXP) has a higher volatility of 26.10% compared to Defiance Quantum ETF (QTUM) at 11.07%. This indicates that ACXP's price experiences larger fluctuations and is considered to be riskier than QTUM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ACXP | QTUM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.10% | 11.07% | +15.03% |
Volatility (6M)Calculated over the trailing 6-month period | 120.56% | 25.30% | +95.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 187.24% | 30.57% | +156.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 140.07% | 27.47% | +112.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 140.42% | 27.59% | +112.83% |
Dividends
ACXP vs. QTUM - Dividend Comparison
ACXP has not paid dividends to shareholders, while QTUM's dividend yield for the trailing twelve months is around 0.82%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
ACXP Acurx Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QTUM Defiance Quantum ETF | 0.82% | 1.01% | 0.61% | 0.81% | 1.46% | 0.48% | 0.42% | 0.61% | 0.21% |
Frequently Asked Questions
ACXP and QTUM have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ACXP has higher volatility (26.10%) compared to QTUM (11.07%). In terms of maximum drawdown, ACXP dropped -99.14% vs QTUM's -38.45%.
QTUM currently has the higher Sharpe Ratio (1.79 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ACXP and QTUM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer